Next move could be to acquire the remaining 50% of BioJet Groups. As more income is generated further acquisitions. Cash flow positive with huge market potential and future acquisitions. The company business model should drive this share price in a steady upward trend as the company grows. Great short, medium or long term investment potential and extremely cheap, cheap. Not too many crosses with this one and management appear to be very focused on their business strategy. Re rate is due. All IMO.
IBN Price at posting:
2.1¢ Sentiment: Hold Disclosure: Held